Literature DB >> 4821037

Editorial: Mental changes in Parkinsonism.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4821037      PMCID: PMC1610154          DOI: 10.1136/bmj.2.5909.1

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  7 in total

1.  ARTERIOSCLEROSIS IN PARKINSONISM.

Authors:  M J EADIE; J M SUTHERLAND
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-06       Impact factor: 10.154

2.  Mental symptoms in parkinsonism following benzhexol hydrochloride therapy.

Authors:  H B PORTEOUS; D N ROSS
Journal:  Br Med J       Date:  1956-07-21

3.  Permanent dementia in idiopathic Parkinsonism treated with levodopa.

Authors:  S M Wolf; R L Davis
Journal:  Arch Neurol       Date:  1973-10

Review 4.  Parkinsonism--neuropathology.

Authors:  P D Lewis
Journal:  Br Med J       Date:  1971-09-18

5.  Oral L-dopa treatment of parkinsonism.

Authors:  N E Andén; A Carlsson; J Kerstell; T Magnusson; R Olsson; B E Roos; B Steen; G Steg; A Svanborg; G Thieme; B Werdinius
Journal:  Acta Med Scand       Date:  1970-04

6.  Intellectual impairment in Parkinson's syndrome.

Authors:  A W Loranger; H Goodell; F H McDowell; J E Lee; R D Sweet
Journal:  Brain       Date:  1972       Impact factor: 13.501

7.  The prevalence, natural history and dementia of Parkinson's disease.

Authors:  M Pollock; R W Hornabrook
Journal:  Brain       Date:  1966-09       Impact factor: 13.501

  7 in total
  2 in total

Review 1.  Adverse effects of antiparkinsonian drugs.

Authors:  J D Parkes
Journal:  Drugs       Date:  1981-05       Impact factor: 9.546

2.  Regenerative lineages and immune-mediated pruning in lung cancer metastasis.

Authors:  Ashley M Laughney; Jing Hu; Nathaniel R Campbell; Samuel F Bakhoum; Manu Setty; Vincent-Philippe Lavallée; Yubin Xie; Ignas Masilionis; Ambrose J Carr; Sanjay Kottapalli; Viola Allaj; Marissa Mattar; Natasha Rekhtman; Joao B Xavier; Linas Mazutis; John T Poirier; Charles M Rudin; Dana Pe'er; Joan Massagué
Journal:  Nat Med       Date:  2020-02-10       Impact factor: 53.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.